|
HIVEP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.915430E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.170100E-04 |
| Normal-vs-Stage2 |
2.529000E-01 |
| Normal-vs-Stage3 |
1.082970E-01 |
| Normal-vs-Stage4 |
8.364600E-01 |
| Stage1-vs-Stage2 |
2.714200E-01 |
| Stage1-vs-Stage3 |
8.111800E-02 |
| Stage1-vs-Stage4 |
4.199000E-04 |
| Stage2-vs-Stage3 |
9.153800E-01 |
| Stage2-vs-Stage4 |
3.075000E-01 |
| Stage3-vs-Stage4 |
1.549960E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.757500E-04 |
| Normal-vs-AfricanAmerican |
1.036630E-01 |
| Normal-vs-Asian |
8.256000E-02 |
| Caucasian-vs-AfricanAmerican |
9.692000E-01 |
| Caucasian-vs-Asian |
6.083000E-01 |
| AfricanAmerican-vs-Asian |
7.586800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.553800E-02 |
| Normal-vs-Female |
8.783700E-04 |
| Male-vs-Female |
1.216030E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.010200E-04 |
| Normal-vs-Age(41-60Yrs) |
2.271700E-02 |
| Normal-vs-Age(61-80Yrs) |
3.633200E-01 |
| Normal-vs-Age(81-100Yrs) |
2.959600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.129700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.295900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.309600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.416600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.778000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.668200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.055000E-03 |
| Classical-VS-Follicular |
9.36730000011821E-07 |
| Classical-VS-Other |
2.126400E-01 |
| Classical-VS-Normal |
3.8750999999948E-06 |
| Tall-VS-Follicular |
2.494600E-01 |
| Tall-VS-Other |
8.451800E-01 |
| Tall-VS-Normal |
5.819000E-01 |
| Follicular-VS-Other |
7.199600E-01 |
| Follicular-VS-Normal |
4.727000E-01 |
| Other-VS-Normal |
9.154800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.915940E-02 |
| Normal-vs-N1 |
2.352800E-01 |
| N0-vs-N1 |
4.023400E-01 |
|
|
